Why severe COVID-19 patients are at greater risk of developing depression: a molecular perspective.

Bouças AP, Rheinheimer J, Lagopoulos J. Neuroscientist. 2022;28(1):11-19.

Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis.

Smith ER, Oakley E, Grandner GW, et al. BMJ Global Health. 2023;8(1):e009495.

COVID-19 in children. II: pathogenesis, disease spectrum and management.

Howard-Jones AR, Burgner DP, Crawford NW, et al. J Paediatr Child Health. 2022;58(1):46-53.

Cancer, more than a "COVID-19 co-morbidity".

Jani CT, Schooley RT, McKay RR, et al. Front Oncol. 2023;13:1107384.

Inflammation at the crossroads of COVID-19, cognitive deficits and depression.

Lyra E Silva NM, Barros-Aragão FGQ, De Felice FG, et al. Neuropharmacology. 2022;209:109023.

Treatment of MIS-C in children and adolescents.

Mahmoud S, El-Kalliny M, Kotby A, et al. Curr Pediatr Rep. 2022;10(1):1-10.

COVID-19 and persons with substance use disorders: inequities and mitigation strategies.

Melamed OC, Hauck TS, Buckley L, et al. Subst Abus. 2020;41(3):286-291.

Serum neutralization of Omicron XBB.1.5 in kidney transplant recipients after bivalent mRNA booster vaccination.

Pedersen RM, Bang LL, Holm DK, et al. Kidney Int Rep. 2023. [Epub ahead of print]

Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection.

Peluso MJ, Spinelli MA, Deveau T-M, et al. AIDS. 2022;36(12):F7-F16.

Triple jeopardy: disabled people and the COVID-19 pandemic.

Shakespeare T, Ndagire F, Seketi QE. Lancet. 2021;397(10282):1331-1333.

The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States.

Tai DBG, Shah A, Doubeni CA, et al. Clin Infect Dis. 2021;72(4):703-706.

Aging, inflammaging and immunosenescence as risk factors of severe COVID-19.

Tizazu AM, Mengist HM, Demeke G. Immun Ageing. 2022;19(1):53.

Severity of COVID-19 among solid organ transplant recipients in Canada, 2020–2021: a prospective, multicentre cohort study.

Hall VG, Solera JT, Al-Alahmadi G, et al. CMAJ. 2022;194(33):E1155-E1163.

The intersection of COVID-19 and cancer: signaling pathways and treatment implications.

Zong Z, Wei Y, Ren J, et al. Mol Cancer. 2021;20(1):76.

Breakthrough SARS-CoV-2 infections in patients with immune-mediated disease undergoing B cell-depleting therapy: a retrospective cohort analysis.

Calabrese CM, Kirchner E, Husni EM, et al. Arthritis Rheumatol. 2022;74(12):1906-1915.

COVID-19 in patients with chronic lung disease.

Calver JF, Fabbri L, May J, et al. Clin Chest Med. 2023;44(2):385-393.

Metabolic syndrome and the risk of COVID-19 infection: a nationwide population-based case-control study.

Cho DH, Choi J, Gwon JG. Nutr Metab Cardiovasc Dis. 2021;31(9):2596-2604.

COVID-19 and liver disease.

Dufour JF, Marjot T, Becchetti C, et al. Gut. 2022;71(11):2350-2362.

Association between diabetes severity and risks of COVID-19 infection and outcomes.

Floyd JS, Walker RL, Kuntz JL, et al. J Gen Intern Med. 2023;38(6):1484-1492.

Hypertension and COVID-19: current evidence and perspectives.

Gallo G, Calvez V, Savoia C. High Blood Press Cardiovasc Prev. 2022;29(2):115-123.

Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.

Han H, Yang L, Liu R, et al. Clin Chem Lab Med. 2020;58(7):1116-1120.

Early experience with modified dose nirmatrelvir/ritonavir in dialysis patients with coronavirus disease 2019.

Hiremath S, Blake PG, Yeung A, et al. Clin J Am Soc Nephrol. 2023;18(4):485-490.

Cardiovascular morbidity and mortality in COVID-19: a multicenter retrospective analysis.

Hmoud H, Morrow Z, DeGregorgio L, et al. Int J Heart Vasc Syst. 2022;2(1):1-6.

Systematic review with meta-analysis: COVID-19 outcomes in patients receiving anti-TNF treatments.

Kokkotis G, Kitsou K, Xynogalas I, et al. Aliment Pharmacol Ther. 2022;55(2):154-167.

COVID-19 and cardiovascular diseases: a literature review from pathogenesis to diagnosis.

Naeem A, Tabassum S, Gill S, et al. Cureus. 2023;15(3):e35658.

Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial.

Reis G, dos Santos Moreira Silva EA, Medeiros Silva DCM, et al. Lancet Reg Health Am. 2022;6:100142.

Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.

Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, et al. J Neurol Sci. 2021;428:117607.

Coronavirus disease-2019 and stroke: pathophysiology and management.

Small C, Mehkri Y, Panther E, et al. Can J Neurol Sci. 2023;50(4):495-502.

Obesity impact on SARS-CoV-2 infection: pros and cons "obesity paradox"—a systematic review.

Vulturar DM, Crivii CB, Orăsan OH, et al. J Clin Med. 2022;11(13):3844.

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy.

Wang D, Leo C, Liu L, et al. Stroke Vasc Neurol. 2023. [Epub ahead of print]

Impact of metabolic syndrome on severity of COVID-19 illness.

Wu S, Zhou K, Misra-Hebert A, et al. Metab Syndr Relat Disord. 2022;20(4):191-198.